Asparlas Side Effects

Generic name: calaspargase pegol

Medically reviewed by Drugs.com. Last updated on Jun 21, 2024.

Note: This document provides detailed information about Asparlas Side Effects associated with calaspargase pegol. Some dosage forms listed on this page may not apply specifically to the brand name Asparlas.

Applies to calaspargase pegol: intravenous solution.

Serious side effects of Asparlas

Along with its needed effects, calaspargase pegol (the active ingredient contained in Asparlas) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking calaspargase pegol:

More common side effects

• bloating
• chills
• constipation
• dark urine
• difficulty breathing
• fast heartbeat
• fever
• indigestion
• loss of appetite
• nausea
• pain in the chest, groin, or legs, especially the calves
• pains in the stomach, side, or abdomen, possibly radiating to the back
• severe, sudden headache
• slurred speech
• sudden loss of coordination
• sudden, severe weakness or numbness in the arm or leg
• vision changes
• vomiting
• yellow eyes or skin

Less common side effects

• bleeding gums
• chest pain or discomfort
• confusion
• cough
• coughing up blood
• difficulty in swallowing
• dilated neck veins
• dizziness
• extreme tiredness or weakness
• fainting
• slow or irregular heartbeat
• headache
• increased menstrual flow or vaginal bleeding
• itching in the genital or other skin areas
• lightheadedness
• nosebleeds
• paralysis
• prolonged bleeding from cuts
• rapid, shallow breathing
• red or black, tarry stools
• red or dark brown urine
• scaling of the skin
• sneezing
• sore throat
• swelling of the face, fingers, feet, or lower legs
• tightness in the chest
• weight gain

Other side effects of Asparlas

Some side effects of calaspargase pegol may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common side effects

• diarrhea

For healthcare professionals

Applies to calaspargase pegol: intravenous solution.

Hematologic adverse events

• Very common (10% or more): Abnormal clotting (e.g., activated partial thromboplastin time prolonged, blood fibrinogen decreased; diarrhea: colitis, diarrhea, enterocolitis, neutropenic colitis) (14%)
• Common (1% to 10%): Embolic/thrombotic events (e.g., device related thrombosis, disseminated intravascular coagulation, embolism, intracardiac thrombus, intracranial venous sinus thrombosis, pulmonary embolism, superior sagittal sinus thrombosis, thrombosis in device, venous thrombosis, venous thrombosis limb), hemorrhage (e.g., disseminated intravascular coagulation, epistaxis, hematoma, hemorrhage intracranial, melena, esophageal ulcer hemorrhage, small intestinal hemorrhage, upper GI hemorrhage)^[Ref]

Hypersensitivity

• Common (1% to 10%): Hypersensitivity^[Ref]

Immunologic

• Common (1% to 10%): Sepsis (e.g., bacterial sepsis, sepsis), fungal infection (e.g., fungal infection, hepatic infection fungal, respiratory tract infection fungal, splenic infection fungal, systemic candida)
• Frequency not reported: Immunogenicity^[Ref]

Hepatic

• Very common (10% or more): Elevated transaminase (e.g., alanine aminotransferase increased, aspartate aminotransferase increased, transaminases increased) (52%), bilirubin increased (e.g., bilirubin conjugated increased, blood bilirubin increased) (20%)^[Ref]

Respiratory

• Common (1% to 10%): Dyspnea (e.g., hypoxia, respiratory failure), pneumonia (e.g., lung infection, pneumonia, pneumonitis)^[Ref]

Cardiovascular

• Common (1% to 10%): Arrhythmia (e.g., atrioventricular block complete, sinus tachycardia, ventricular arrhythmia), cardiac failure (e.g., ejection fraction decreased, left ventricular dysfunction)^[Ref]

Gastrointestinal

• Very common (10% or more): Pancreatitis (e.g., amylase increased, lipase increased, pancreatic necrosis, pancreatitis, pancreatitis relapsing) (18%)
• Common (1% to 10%): Diarrhea^[Ref]

Frequently asked questions

• How does Asparlas (calaspargase pegol-mknl) compare to Oncaspar (pegaspargase)?

Further information

Asparlas side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer